None
Quote | Veracyte Inc. (NASDAQ:VCYT)
Last: | $19.83 |
---|---|
Change Percent: | -0.15% |
Open: | $19.88 |
Close: | $19.83 |
High: | $20.7 |
Low: | $19.81 |
Volume: | 563,698 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Veracyte Inc. (NASDAQ:VCYT)
Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at ...
Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate cancer, the Decipher Prostate Genomic Classifier is prognostic for ident...
Message Board Posts | Veracyte Inc. (NASDAQ:VCYT)
Subject | By | Source | When |
---|---|---|---|
Anyone hear anything lately? Want to see this one go | Alan Brown | investorshub | 04/25/2023 10:31:30 PM |
must see | gumibear | investorshub | 04/24/2023 8:49:57 PM |
short squeeze signal | Gixene | investorshub | 04/23/2023 7:42:51 AM |
what does this mean? | ClayTrader | investorshub | 04/23/2023 7:13:01 AM |
$VCYT The gaining | Alan Brown | investorshub | 04/23/2023 6:40:05 AM |
News, Short Squeeze, Breakout and More Instantly...
Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at ...
Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate cancer, the Decipher Prostate Genomic Classifier is prognostic for ident...
Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that nine abstracts focused on its Decipher Prostate and Decipher Bladder Genomic Classifiers will be presented at AUA 2024, the annual meeting of the American Urological Association, taking place May 3-6 in S...